Lifestyle Changes in Fatty Liver; Additive Effect of Honey Intake

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-50
SponsorCairo University

About this trial

honey is a natural functional food used in control cardiovascular risk factors but its effect on fatty liver is not investigated

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

fatty liver (non alcoholic form)

both sexes included

obese subjects (class I)

Disqualifiers

cardiac insult

respiratory insult

renal insult

lower limb insult

Trial design

Design model

Parallel

Treatments tested in this trial

  • honey intake and lifestyle changes

    Behavioral

    Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive natural unprocessed honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks.

  • lifestyle changes

    Behavioral

    Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive low calorie diet and treadmill walking (40 minutes per session, three times per week) for 12 weeks.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: honey intake and lifestyle changesExperimental treatment 1 intervention
Group B: lifestyle changesActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

High density lipoprotein

it will be measured in serum

Time frame
it will be assessed after 12 weeks

Secondary outcomes

1

triglycerides

it will be measured in serum

Time frame
it will be assessed after 12 weeks
2

cholesterol

it will be measured in serum

Time frame
it will be assessed after 12 weeks
3

low density lipoprotein

it will be measured in serum

Time frame
it will be assessed after 12 weeks
4

alanine transamianse

it will be measured in serum

Time frame
it will be assessed after 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.